eFFECTOR Therapeutics Inc
F:LWK1

Watchlist Manager
eFFECTOR Therapeutics Inc Logo
eFFECTOR Therapeutics Inc
F:LWK1
Watchlist
Price: 9.1 EUR Market Closed
Market Cap: 1.1m EUR

Operating Margin
eFFECTOR Therapeutics Inc

0%
Current
-1 679%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.7m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

eFFECTOR Therapeutics Inc
Glance View

Market Cap
1.1m EUR
Industry
Biotechnology

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). The company is headquartered in Solana Beach, California and currently employs 13 full-time employees. The company went IPO on 2021-01-08. The firm is focused on the development of oncology drugs, such as selective translation regulator inhibitors (STRIs). The company uses selective translation regulation technology platform to internally discover a portfolio of small molecule STRI product candidates. Its product candidates target the eIF4F complex and its activating kinase, MNK. The firm's lead product candidate, tomivosertib, is an inhibitor of MNK, and is being evaluated in combination with KEYTRUDA (pembrolizumab), an inhibitor of programed cell death protein 1 (PD-1) in a randomized Phase IIb clinical trial in patients with metastatic non-small cell lung cancer (NSCLC). Its second product candidate, zotatifin, is an inhibitor of eIF4A, a component of the eIF4F complex, and is being evaluated in a Phase I/II clinical trial in patients with certain solid tumors. Its third program is focused on developing inhibitors of eIF4E.

LWK1 Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.7m
/
Revenue
0
What is the Operating Margin of eFFECTOR Therapeutics Inc?

Based on eFFECTOR Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top